Silence Therapeutics plc (SLN)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

4 annual periodsNewest to oldest
2025202420232022
Revenue$559,000$43.3M$31.6M$21.7M
Gross profit$344,000$31.4M$18.8M$8.2M
Research & development$67.8M$67.9M$56.9M$43.5M
Operating income−$91.1M−$63.3M−$64.4M−$61.0M
Net income−$88.6M−$45.3M−$54.2M−$50.3M
Basic EPSper diluted share-$0.63-$0.33-$0.49-$0.52
Diluted EPSper diluted share-$0.63-$0.33-$0.49-$0.52

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys63$0.00 disclosed value
Sells (SEC code S)2$0.00 disclosed value
65 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Oct 27, 2025Form 4Griffiths Richard IanTenPercentOwnerBuyAmerican Depositary Shares · derivative · indirect2.0K11.83M
Oct 27, 2025Form 4Griffiths Richard IanTenPercentOwnerSellAmerican Depositary Shares · derivative · indirect2.0K11.82M
Aug 3, 2025Form 4Griffiths Richard IanTenPercentOwnerBuyAmerican Depositary Shares · derivative · indirect20.0K11.83M
Aug 3, 2025Form 4Griffiths Richard IanTenPercentOwnerSellAmerican Depositary Shares · derivative · indirect20.0K11.81M
Aug 1, 2025Form 4Griffiths Richard IanTenPercentOwnerBuyAmerican Depositary Shares · derivative · indirect4.0K11.83M